http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017160864-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d82baf295e3e7947db9b0746e0ac1a7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_763fb198e0da7d99091b8f740008e1de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa413cd413c0c887907385187077464a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f6adc44610f208ee8443dfb49a144c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aff391a1a8fd8eda8bdc33726c71f50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b3c9e31549d19f37cc99955e0b8e859
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f7f4449badbd570cd422ce6a5fdc60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55901125fdf138d0e1f86d555106b8e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8c2f0330b280dd3f6f5a88932cc4b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e49917d94f57a7ca299fe11b01452880
publicationDate 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017160864-A8
titleOfInvention Hydralazine and active derivatives thereof for neuronal cell survival and regeneration
abstract The present invention includes a method of protecting or treating neural cells from degeneration comprising: identifying a neural cell in need of protection from at least one of radical oxidative stress, increased mitochondrial biogenesis, decreased intracellular protein aggregation or neurofibrillary tangles, increase of at least one of cellular NAD or ATP levels, activation of autophagy, removal of protein aggregates, prevents GSK3β or Tau protein phosphorylation, or increase neuronal plasticity; and providing the neural cell with a therapeutically effective amount of a hydralazine or active bioequivalent thereof sufficient to reduce radical oxidative stress, increase mitochondrial biogenesis, decrease intracellular protein aggregation or neurofibrillary tangles, increase of at least one of cellular NAD or ATP levels, activate autophagy, remove protein aggregates, prevent GSK3β or Tau protein phosphorylation, or increase neuronal plasticity, thereby protecting the neural cells from degeneration.
priorityDate 2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID418335
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478575
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84027
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3637
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID790875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399128

Total number of triples: 38.